Bradley Foster & Sargent’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-5,223
| Closed | -$986K | – | 449 |
|
|
2021
Q3 | $986K | Hold |
5,223
| – | – | 0.02% | 233 |
|
|
2021
Q2 | $885K | Sell |
5,223
-1,622
| -24% | -$275K | 0.02% | 244 |
|
|
2021
Q1 | $966K | Sell |
6,845
-3,453
| -34% | -$487K | 0.02% | 228 |
|
|
2020
Q4 | $1.34M | Buy |
+10,298
| New | +$1.34M | 0.04% | 201 |
|
|
2018
Q3 | – | Sell |
-3,175
| Closed | -$313K | – | 368 |
|
|
2018
Q2 | $313K | Sell |
3,175
-2,120
| -40% | -$209K | 0.01% | 314 |
|
|
2018
Q1 | $631K | Sell |
5,295
-2,940
| -36% | -$350K | 0.02% | 252 |
|
|
2017
Q4 | $1.05M | Hold |
8,235
| – | – | 0.04% | 215 |
|
|
2017
Q3 | $968K | Buy |
8,235
+4,120
| +100% | +$484K | 0.04% | 217 |
|
|
2017
Q2 | $328K | Hold |
4,115
| – | – | 0.01% | 298 |
|
|
2017
Q1 | $211K | Buy |
+4,115
| New | +$211K | 0.01% | 324 |
|
|
2016
Q4 | – | Sell |
-4,115
| Closed | -$279K | – | 343 |
|
|
2016
Q3 | $279K | Hold |
4,115
| – | – | 0.01% | 303 |
|
|
2016
Q2 | $228K | Buy |
+4,115
| New | +$228K | 0.01% | 313 |
|
|
2015
Q1 | – | Sell |
-2,500
| Closed | -$242K | – | 356 |
|
|
2014
Q4 | $242K | Buy |
+2,500
| New | +$242K | 0.01% | 312 |
|
|
2014
Q3 | – | Sell |
-3,500
| Closed | -$221K | – | 354 |
|
|
2014
Q2 | $221K | Buy |
+3,500
| New | +$221K | 0.01% | 322 |
|
|
2013
Q4 | – | Sell |
-3,400
| Closed | -$218K | – | 344 |
|
|
2013
Q3 | $218K | Buy |
+3,400
| New | +$218K | 0.01% | 312 |
|